Non-Performing Assets / Total Loans: A classification used by financial institutions that refer to loans that are in jeopardy of default as a potion of total loans made. Calculated as: Non-Perfroming Assets / Gross Loans Made
Royalty Pharma PLC (RPRX) Non-Performing Assets / Total Loans data is not available.
| Income Statement Financials | |
$2.35B |
|
$1.13B |
|
-- |
|
$2.35B |
|
$862.40M |
|
$1.49B |
|
$207.94M |
|
$1.70B |
|
$1.47B |
|
$1.70B |
|
$1.70B |
|
$1.70B |
|
$1.47B |
|
$1.49B |
|
$1.51B |
|
447.60M |
|
602.90M |
|
$2.54 |
|
$2.53 |
|
| Balance Sheet Financials | |
$1.27B |
|
$14.09B |
|
$15.11B |
|
$16.38B |
|
$161.38M |
|
$6.14B |
|
$6.14B |
|
$6.30B |
|
$10.08B |
|
$10.08B |
|
$10.08B |
|
982.12M |
|
| Cash Flow Statement Financials | |
$2.99B |
|
$-2.07B |
|
$-2.15B |
|
$1.71B |
|
$477.01M |
|
$-1.23B |
|
$2.36M |
|
$-854.85M |
|
-- |
|
| Fundamental Metrics & Ratios | |
7.90 |
|
|
Non-Performing Assets / Total Loans |
-- |
-- |
|
0.38 |
|
0.61 |
|
100.00% |
|
63.37% |
|
63.37% |
|
64.24% |
|
72.20% |
|
48.20% |
|
$2.99B |
|
-- |
|
-- |
|
-- |
|
0.14 |
|
-- |
|
64.25 |
|
5.68 |
|
16.86% |
|
16.86% |
|
10.38% |
|
10.48% |
|
$10.27 |
|
$4.96 |
|
$4.96 |
|